The ICGC collects data through large-scale sequencing projects. Researchers collect tumor and matched normal tissue samples from cancer patients, followed by whole genome sequencing, exome sequencing, and RNA sequencing. The data is then analyzed to identify somatic mutations, copy number variations, and other genetic alterations. Bioinformatics tools and computational methods are employed to interpret the data and understand the underlying mechanisms driving cancer development and progression.
